Potentiating Gentamicin Efficacy Against Biofilms of Clinically Relevant Gram-Negative Bacteria Using Biosynthesized ZnO Nanoparticles
Pharmaceutics · 24.07.2026 · 18 (8) · 913
DOI: 10.3390/pharmaceutics18080913 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 24.07.2026. Verfasst von Akshit Malhotra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Delhi South Campus, Benito Juarez Road, New Delhi 110021, India. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research, Department of Science and Technology, ICMR.
Abstract (Originalsprache)
Background
Gram-negative bacteria resistant to multiple drugs are a major cause of illness and death worldwide. Their remarkable capacity to develop resistance to antibiotics makes them a serious concern in medical practice.
Methods
A simple, green, novel method is used to synthesize ZnO nanoparticles (ZnO NPs) using ethanolic extracts of Diplazium esculentum via precipitation.
Results
ZnO NPs exhibit a hexagonal structure with a particle size of ~30 nm and a band gap of 3.24 eV. The defect sites formed in ZnO NPs were estimated using prominent peaks in the photoluminescence spectra. ZnO NPs displayed a more than 4-log reduction in multi-drug-resistant E. coli and K. pneumoniae clinical isolates at a 500 μg/mL concentration. Moreover, ZnO NPs significantly reduced the biofilm bacterial cell viability of clinical isolates of Gram-negative bacteria. Complete eradication of biofilms was achieved for drug-resistant E. coli clinical isolates using a combination of sub-MIC of gentamicin and 500 μg/mL ZnO NPs. Green-synthesized ZnO NPs did not induce oxidative stress in mice, as indicated by unchanged GST, GSH, and thiol levels across all the tested organs. ZnO NPs showed both antibacterial and antibiofilm efficacy against drug-resistant strains of E. coli, K. pneumoniae, and S. aureus and completely eradicated E. coli biofilm in combination with gentamicin.
Conclusions
Our study focuses on the sustainable synthesis of biocompatible ZnO NPs for the treatment of infections caused by pathogens belonging to the high-priority ESKAPE group.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, University of Delhi South Campus, Benito Juarez Road, New Delhi 110021, India.
- Department of Microbiology, Tripura University (A Central University), Suryamaninangar, Agartala 799022, India.
- The Madras Medical Mission, 4-A Dr JJ Nagar Mogappair, Chennai 600053, India.
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kreml uramı 18, 420008 Kazan, Republic of Tatarstan, Russia.
ORCID-Profile: Kwthar Debbarma, Ram Karan, Ashwini Chauhan
Förderung
- Indian Council of Medical Research
- Department of Science and Technology
- ICMR
- DST-Nanomission
Zitieren
APA
Malhotra, A., Debbarma, K., Jana, S., Dhinakaran, I., Prasanthi, S. J., Rozhina, E., Karan, R., & Chauhan, A. (2026). Potentiating Gentamicin Efficacy Against Biofilms of Clinically Relevant Gram-Negative Bacteria Using Biosynthesized ZnO Nanoparticles. Pharmaceutics, 18(8), 913. https://doi.org/10.3390/pharmaceutics18080913
Vancouver
Malhotra A, Debbarma K, Jana S, Dhinakaran I, Prasanthi SJ, Rozhina E, et al. Potentiating Gentamicin Efficacy Against Biofilms of Clinically Relevant Gram-Negative Bacteria Using Biosynthesized ZnO Nanoparticles. Pharmaceutics. 2026;18(8):913. doi:10.3390/pharmaceutics18080913
BibTeX
@article{Malhotra2026,
author = {Malhotra, Akshit and Debbarma, Kwthar and Jana, Sangita and Dhinakaran, Irusan and Prasanthi, Surisetty Jaya and Rozhina, Elvira and Karan, Ram and Chauhan, Ashwini},
title = {Potentiating Gentamicin Efficacy Against Biofilms of Clinically Relevant Gram-Negative Bacteria Using Biosynthesized ZnO Nanoparticles},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {8},
pages = {913},
doi = {10.3390/pharmaceutics18080913}
}
EUVIMED